Top Markets
#1 Official Trump Official Trump +51.60%
#2 Movement Movement +32.33%
#3 Mubarak Mubarak +26.27%
#4 Pearl Pearl +24.49%
#5 Zama Zama +24.44%
#6 Melania Meme Melania Meme +22.38%
#7 EXOD EXOD +18.93%
#8 Wrapped POL Wrapped POL +18.74%
#9 POL (ex-MATIC) POL (ex-MATIC) +18.66%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +16.92%
Coin of the day
Official Trump Official Trump
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Citius Oncology, Inc. Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
Classement en actions #23802
Citius Oncology, Inc. concentrates on advancing innovative, targeted... Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
Prix de l'action
$0.7426
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$69.05M
Changement (1 jour)
-2.17%
Changement (1 an)
-57.57%
Pays
US
Échange Citius Oncology, Inc. (CTOR)

Catégorie

Healthcare
Ratio P/S pour Citius Oncology, Inc. (CTOR)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Citius Oncology, Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Citius Oncology, Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.95 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.41 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
6.85 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.05 -
US